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ABSTRACT
Transcatheter aortic valve implantation (T-AVI) has shown good results in high-risk patients with
severe aortic stenosis. Throughout the whole process of T-AVI, different imaging modalities are
indispensable. Preoperatively, multislice computed tomography, angiography and transesophageal
echo (TEE) are utilized for patient selection, valve selection, approach selection and the planning of
implant placement. Intraoperatively, angiography and TEE are used for controlling placement of the
guidewire and valve positioning. Quality control and follow-up require TEE imaging and can require
additional CT or angiography studies. In the first half of this paper, we discuss the applicability of
different imaging modalities for T-AVI in the light of the current best practice.
In the second half of this paper, we present an overview on research projects in medical
engineering which aim at development of image-based methods for increasing patient safety during
T-AVI. Template-based implantation planning, as it is applied in dental, orthopedic and other surgical
disciplines, is proposed as an aid during implant selection in order to help reduce the incidence of
complications such as atrioventricular node block and paravalvular leaks. Current research tries to
apply state-of-the-art engineering techniques, such as computational fluid dynamics to optimize
valve selection and positioning. For intraoperative assistance during valve positioning, real-time
image processing methods are proposed to track target landmarks and the stented valve.
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BACKGROUND
Transcatheter aortic valve implantation (T-AVI) was first described by Cribier in 2002 [1] and since
then has evolved as a routine procedure for high risk patients with aortic stenosis [2,3]. As of June
2010, 10,000 transfemoral (TF) implants of the CoreValveTMprosthesis (Medtronic Inc., Minneapolis,
MN, USA) and approximately a similar number of TF and transapical (TA) implants of the Edwards
SapienTMprosthesis (Edwards Lifesciences Inc., Irvine, CA, USA) (Fig. 1, left) have been reported.
Several additional systems are currently being developed or tested [4,5].
Several studies have proven the efficacy and efficiency of the method [3,6,7]. With respect to
mortality, T-AVI clearly outperforms medical therapy in patients who are not surgical candidates [8].
Whether or under which circumstances T-AVI has better results than surgical valve replacement has
not yet been established. Recent studies were able to show that the short-term and mid-term
mortality of T-AVI patients are clearly below the logistic EuroScore for patients with high operative
risks. Randomized data comparing T-AVI with surgical valve replacement are still pending.
COMPLICATIONS
The most common complication after T-AVI is third-degree atrioventricular block (AVB) with an
incidence reported up to 36% [3,6,7]. Stimulus conduction through the AV node can be permanently
interrupted through pressure induced on the tissue by the expanded stent in the left ventricular
outflow tract (LVOT). Several studies indicate that inordinate valve oversizing, low valve implantation,
device type, pre-existing right bundle branch block and severe calcifications in the area of the
coronary sinus promote AVB after T-AVI [9---11]. If persistent, bradycardia resulting from AVB requires
permanent pacemaker implantation.
Paravalvular leaks are the most common reason for postoperative aortic insufficiency (AI) after
T-AVI (4%---35% [7]. Valve misplacement, eccentric local plaque and insufficient oversizing are the
principal reasons for this complication [9].
Aortic dissection or perforation is reported between 0% and 4% [7]. Partial or complete coronary
occlusion was reported in 0.6% of T-AVI cases in the SOURCE registry [3] (Fig. 2).
In most cases, the occlusion is caused by the displaced native leaflet rather than by the implant
itself. Risk factors are excessive calcifications, a low coronary ostium (<10---12 mm from the basal
leaflet insertion to coronary ostium), a narrow aortic root with shallow sinuses or combinations of
these factors [12]. In such cases careful planning of the implant target position might prevent
coronary occlusion.
Valve embolization due to implant undersizing or misplacement is reported in rare cases, e.g. 0.3
% in the SOURCE registry. Rare cases of aortic root rupture (e.g. [13] are reported. Causes for these
events are unclear; valve oversizing or local calcifications might promote them.
THE ROLE OF IMAGING
Preoperative and intraoperative imaging is of utmost importance for procedural planning and
execution. Preoperatively information on: (1) vascular access sites; (2) quality and tortuosity of the
femoral, iliac vessels and the whole aorta; (3) relation of the apex to the chest wall; (4) angulation of
Figure. 1 Left: Transapical implantation of balloon-expanded T-AVI valve (schematic), Right: Transapical
implantation of self-expanding T-AVI valve (schematic).
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the left ventricle and left ventricular outflow tract in relation to the aortic root; (5) aortic valve leaflets
and leaflet calcification; (6) aortic valve annular dimension, geometry and calcification; (7) distance
of coronary ostia from aortic annulus; (8) the extent of concomitant coronary artery disease; (9)
concomitant valvular pathology, and (10) left ventricular function need to be determined.
Intraoperatively, fluoroscopy and TEE are used to: (1) guide wire placement; (2) perform root
angiography; (3) guide positioning of the balloon for balloon valvuloplasty; (4) position the implant,
and (5) for quality control. There is a consensus that for intraoperative guidance both high-resolution
fluoroscopy as well as TEE is required. In this paper we will describe the use of different imaging
modalities in the preparation, conduction and follow-up of T-AVI.
IMPLANTATION PLANNING
The percutaneous nature of T-AVI forbids manual implant sizing during the intervention. Once
implanted, percutaneous implants can only be removed surgically, requiring conversion to an open
heart technique. To prevent this, T-AVI requires precise and extensive preoperative planning.
PATIENT SELECTION
Careful T-AVI planning begins with careful patient selection. There are general indications and
contraindications for T-AVI. In addition, there are specific indications and contraindications for the
transfemoral and transapical approach and for the available valve types that should be considered in
order to select the optimal treatment.
The European Association of Cardio-Thoracic Surgery (EACTS), the European Society of Cardiology
(ESC) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) released a
joint statement which includes elaborate recommendations regarding patient selection for T-AVI [14].
According to these recommendations, T-AVI is indicated in symptomatic patients with confirmed
severe aortic stenosis (AS) who face a high operative risk (expected mortality >20% with the logistic
EuroScore and >10% with the STS score).
Severe coronary comorbidity which requires revascularization is not necessarily a contraindication
for T-AVI, but for those patients who are percutaneous coronary intervention candidates, the
chronology of both interventions should be discussed individually. At present, T-AVI is not
recommended for patients with bicuspid valves [15].
The current gold standard for diagnosis of AS is transthoracic echocardiography
Figure. 2 Main stem occlusion after T-AVI.
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(TTE), transesophageal echocardiography (TEE) or invasive measurement of transvalvular pressure
gradient. Non-invasive assessment of AS is also possible with MRI.
A secondary indication for T-AVI may be major AI without relevant AS, for instance in the case of a
degenerated biological implant. For diagnosis of AI, TTE, TEE, angiography or MRI can be applied.
Non-invasive assessment for both AS and AI is also possible with CT [16,17].
APPROACH SELECTION
Once a patient has been identified as a T-AVI candidate, the decision for the transfemoral or
transapical approach is the next step. So far, no evidence-based guidelines are available for this
decision, but a number of criteria and parameters are reported in the literature which might favor one
approach over the other [14]. Careful evaluation of these parameters before the decision is strongly
recommended to be rendered by an interdisciplinary board including cardiology, cardiac surgery,
radiology, and anaesthesiology.
Feasibility of the transfemoral approach
For the transfemoral approach, a minimum passage (6 mm for the Corevalve, 6---6.5 mm for the
Sapien) through one iliac artery and the aorta is required. Calcifications, vessel tortuosity, aneurysms
of the abdominal aorta, plaque and a narrow bending of the aortic arch may hinder the advancement
of the guidewire and the catheter and may give favor to the transapical approach. The assessment of
the diameter, calcifications and tortuosity of the iliac arteries and of the aorta is possible with
multislice CT angiography (CTA) and projective angiography images. However, CT provides more
comprehensive insights, especially with regards to the circularity of calcifications.
Feasibility of the transapical approach
For the transapical approach, previous surgery of the left ventricle (LV) including a patch and severe
respiratory insufficiency are contraindications. Calcifications of the pericardium, the accessibility of
the apex through a minithoracotomy, a narrow LV, sharp angles between the LVOT centreline, the
centreline of the ascending aorta, the delivery axis through the apex and an intercostal space (Fig. 3)
impede the feasibility of the transapical approach and might give favor to the transfemoral approach.
The feasibility of the transapical approach is best assessed using CTA, but could in principle (and if
the renal status of the patient requires this) also be investigated in 3D TTE and TEE.
ANNULUS MEASUREMENT AND VALVE SIZING
Incorrect valve sizing has been proven to be a principal cause for postoperative aortic insufficiency
due to paravalvular leaks as well as for severe complications such as annular or LVOT ruptures.
Correct sizing of the valve requires a comprehensive understanding of the geometry and topology
of the aortic root and LVOT [18] and accurate measurement of the diameter of the aortic annulus.
Table 1. Applicability of imaging modalities for T-AVI. (••: recommended, •: possible, *: applied
experimentally).
Phase Fluoro/Angio TTE/TEE CT MRI DynaCT
Preparation Grade of Stenosis •• •• •
Coronary Status •• •
Grade of AI •• •• • •
LV Function •• ••
LV & LVOT Geometry •• •• •
Valve Calcification • ••
Root Geometry &
Sizing
• •• • •
Vascular Access •• •• •
Intervention Guide Wires •• •
Valve Positioning •• • * *
Valve Deployment •• • *
Impl. Valve Assessmt. • •• *
LV Function •• *
Coronary Occlusion •• •
Cardiac Tamponade • ••
Follow Up Paravalvular Leaks •• •
Valve Migration • ••
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Manufacturer guidelines originally restricted the usage of the SAPIEN implant to patients with an
aortic annulus diameter between 18 and 25 mm; the Sapien Xt extends this range to 28 mm. The
CoreValve is currently recommended for patients with an aortic annulus between 20 and 27 mm. The
profile of the aortic annulus is (roughly) elliptic. In the literature, different definitions of the diameter
of the aortic root are used (Fig. 4, left): The minimal diameter Dmin , the maximal diameter Dmax , the
mean diameter Dmean=(Dmax+Dmin)/2 , and DCSA=2× (CSA/pi)0.5 which is computed from the cross
sectional area (CSA) of the annulus. According to Schultz et al., [19], Dmean and DCSA produce the best
approximation of a one-dimensional radius for valve selection. In the future, sizing guidelines (and
stent designs) based on the two radii of a fitted ellipse (Fig. 4, right) might increase the outcome
quality of T-AVI.
The highest reproducibility of annulus measurements is reached with CTA images [19,20]. Only
patients whose renal status forbids CTA acquisition, 3D TEE or projected X-ray angiographies should
be used for annulus measurement.
The basic functionalities required for T-AVI planning (determination of diameters, cross-sectional
areas and angles) are available in most modern medical image analysis software. Nevertheless, the
Figure. 3 Angle between LVOT and transapical entry vector through intercostal space.
Figure. 4 Left: Dmin,Dmax,DCSA , Right: Elliptic description of the annulus.
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determination of all relevant parameters (especially the assessment of the femoral approach) can be
an extremely time-consuming process with most off-the-shelf cardiology or radiology systems.
For clinical practice, the 3Mensio Valves software package (3mensio Medical Imaging BV, Bilthofen,
The Netherlands, Fig. 5) implements a dedicated planning workflow for T-AVI which offers specific
tools for most questions that arise during T-AVI planning.
INTRAOPERATIVE IMAGING
X-ray angiography is used to monitor guidewire placement for transfemoral aortic valve implantation
(TF-AVI) as well as for transapical aortic valve implantation (TA-AVI). To confirm correct wire placement
within the LV (especially to rule out interference with the subvalvular apparatus of the mitral valve),
TEE can be supportive.
Accurate valve positioning is the crucial step of T-AVI. The operator has to assure a good
entrenchment of the stent in the aortic annulus in order to achieve an optimal sealing of the annulus
with the stented valve. Occlusion of the coronary ostia has to be avoided as well as impairment of the
mitral valve. To ensure this, online imaging is required which allows identification of the coronary
ostia and the annulus. A new class of anatomically shaped valve stents (Fig. 1, right) raises an
additional issue regarding the orientation of the device. Whereas for implants such as the CoreValve
and the Sapien, the orientation around the length axis (roll angle) is considered to have no influence
on the outcome, these new devices require rotational alignment of the support frame with the cusps
of the sinuses.
The clinical gold standard for imaging during valve placement is X-ray angiography. C-arm
angulation is an important factor for obtaining reliable and conclusive images. The optimal projection
is perpendicular to the annulus plane and orthogonal to the line through both commissures (Fig. 6,
right). TEE is often used as an additional source of information during valve positioning.
Valve deployment is usually performed under angiography monitoring with the TEE probe retracted.
For patients with severe renal disorder, valve positioning and deployment under TEE guidance was
proposed [21].
Throughout the implantation process TEE is used to monitor LV function, which may deteriorate
after valvuloplasty due to acute onset of AV regurgitation and to detect cardiac tamponade.
Figure. 5 T-AVI planning with 3Mensio software. (a) distance between coronary ostia, basal plane, sinuses of
Valsalva. (b) clearwidthof iliac artery is visualized for transfemoral access. (c) Rosenhek classificationof valvular
calcifications.
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Post-implant, the valve position is confirmed with TEE and/or angiography. Valve competence can
be tested with Doppler TEE and angiography, whereby TEE provides better localization and
assessment of paravalvular regurgitation.
Obstruction or occlusion of the coronary arteries is best seen in angiography.
Diagnosis of AVB requires no imaging but is best seen on the ECG. Nevertheless, the impact of both
AVB and left main occlusion on the LV function may be seen in TEE.
FOLLOW-UP
The development of paravalvular leaks, as well as possible valve migration, should be checked in
regular intervals during follow up. TEE should be used for regular screenings; cardiac CT is
recommended in cases where TEE findings are not conclusive or indicate major complications.
FUTURE PROSPECTS
3D ANGIOGRAPHY
With the Syngo DynaCT system (Siemens AG Medical Sector, Erlangen, Germany) volumetric
reconstructions similar to multislice CT images can be acquired intraoperatively with the angiography
C-arm. With respect to resolution, signal to noise ratio, fidelity and motion artefacts, the resulting
images are not comparable with modern cardiac CT images. It has been shown that when acquired
under rapid pacing, they are sufficient for preoperative implant selection [9] and automatic
generation of a 3D model which contains all relevant anatomical landmarks [22].
As long as the patient is not moved on the operating table after DynaCT acquisition, the DynaCT
remains spatially registered with any angiography images acquired with the same C-arm. The optimal
perpendicular view onto the aortic root can be identified by rotating the virtual model of the aortic
root on screen and the system can then rotate the C-arm accordingly. During valve positioning, a 3D
model extracted from the DynaCT can be superimposed on the angiography images used to guide
catheter placement (Fig. 6) [23].
TEMPLATE-BASED PLANNING
The current practice of valve selection is usually based on the annulus radius alone, neglects the fact
that the aortic root is a complex 3D structure that varies among patients with respect to several
parameters [18]. For optimal valve selection the geometry of the aortic root as a whole needs to be
considered. In 2009, the usage of geometric 3D models of the implants (‘implant templates’) was
proposed as a means to give visual feedback on the fit between implant and anatomy during T-AVI
planning [24]. The system guides the user through a landmark detection process that aims to
establish a simplified model of the aortic root anatomy [18]. 3D implant templates of different valve
models are registered according to the manufacturers implant placement guidelines (Fig. 7).
Valve selection and placement can be manually adjusted by the physician. In 2010, a preliminary
study was presented showing that this approach can help to increase the accuracy of implant
selection with respect to the incidence of postoperative AVB and AI [9].
In Fig. 8, the concept of knowledge-based implantation planning is depicted. A database of models
describing the pre- and postoperative status of a cohort of T-AVI patients is created. By relating actual
cases to this knowledge base of past cases, a planning system can automatically derive treatment
Figure. 6 Interoperative fusion of 3D information from DynaCT with 2D angiography.
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plans which reduce the risk for AI, AVB, or other complications. By integrating other future
technologies (such as simulation and catheter guidance as described below), a closed loop of
planning information, treatment assistance and follow-up assessment is created which allows the
system to permanently extend its database.
Figure. 7 3D template-based preoperative T-AVI planning with Emracer and Sapien valve.
Figure. 8 Workflow and dataflow for knowledge-based implant selection and implantation support.
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Figure. 9 Deformation analysis of T-AVI stent: undeformed stent model (left), postoperative CT (center),
deformed stent model (right).
SIMULATION
Numerical simulation of flow conditions through aortic valve implants have been an indispensable
engineering tool in the development of new devices for many years [25]. In recent research, several
groups have applied the same methods for simulating the hemodynamics in the aortic root after
percutaneous valve implantation in a patient specific manner [26]. Analysis of stent deformation
under implantation (Fig. 9) allows patient-specific simulation of the leaflets mechanics to assess
coaptation [27].
In the future, such approaches could be employed for determining the optimal treatment
preoperatively or for postoperative prediction of the long-term outcome, valve degeneration [28] or
valve migration [29].
CATHETER GUIDANCE
The most specific planning is only useful to the extent of accuracy which can be reached regarding
valve placement intraoperatively. Advanced image processing technology and mechatronic systems
could in the future help to avoid placement errors or even actively support positioning of the valve.
A system was presented in 2010 [30] for intraoperative tracking of the coronary ostia as well as the
stented valve. A screenshot of the intraoperative system output is presented in Fig. 10.
Preoperatively, the distance between the coronary ostia and the aortic annulus is measured, e.g. in
DynaCT or multisclice CT images. In a perpendicular projection, the coronary ostia (red dots) are then
used to determine the target area (green box) for the distal perimeter of the stented valve (magenta
box). This development aims at providing passive assistance by preventing the operator to deliver the
device in a position where coronary occlusion is likely to occur. In the current stage this system
cannot be used during surgery as it does not function in real-time.
Intraoperative MRI guided T-AVI was first attempted around the year 2004. It was reported that due
to the radiofrequency shielding effect of ferromagnetic stents, imaging quality was impaired during
and after valve deployment, but was, in principle still possible [31]. Immel et al. presented an
experiment in which they equipped self-expanding stents with resonance circuits to overcome the
shielding effect [32]. The feasibility of MRI guidance of T-AVI can also be increased by attaching
ferromagnetic markers to the stents [33,34]. Some groups, e.g. Li et al. and Yeniaras et al., work on
the development of robotic systems for transapical valve placement under MRI guidance [35,36].
DISCUSSION
During all steps of the T-AVI workflow imaging plays an important role. In order to guarantee safe and
accurate conduction of T-AVI interventions, state-of-the-art imaging equipment and image analysis
software are essential. Multimodality approaches including TEE, X-ray angiography and multislice CT
are promoted as the best practice standard by a number of notable publications. Still, T-AVI is
afflicted with a number of frequent complications. Ongoing research is revealing the reasons for these
complications and leads to the development of new image-based techniques for more accurate
patient selection, intervention planning and valve placement. T-AVI is an interdisciplinary technique,
which requires surgeons, cardiologists, radiologists, and anesthesiologists to find an optimal
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Figure. 10 Interoperative tracking of stented valve and coronary ostia (red dots with and without contrast agent
[karar2010].
treatment for a patient in a cooperative manner. Appropriate image analysis and visualization tools
can help in the formation of and communication within such interdisciplinary teams.
ABBREVIATIONS USED IN THE TEXT
AI Aortic insufficiency
AS Aortic stenosis
AVB Atrioventrciular node block
CT Computed X-ray tomography
CTA CT angiography
LV Left ventricle
LVOT Left ventricular outflow tract
MRI Magnetic resonance imaging
T-AVI Transcatheter aortic valve implantation
TA Transapical
TEE Transesophageal echocardiography
TF Transfemoral
TTE Transthoracic echocardiography
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